Webcast

Updates on the Management of Insomnia: Expert Guidance Through the Latest Clinical Trials on Dual Orexin Receptor Antagonists

Launch Date
06/16/2020
Credit Amount
0.00 Expired
Credit Expires
06/16/2021

Faculty

W. Vaughn McCall, MD, MS
Case Distinguished University Chair
Department of Psychiatry and Health Behavior
Executive Vice Dean Medical College of Georgia
Augusta University Augusta, GA
W. Vaughn McCall, MD, MS
Case Distinguished University Chair

Dr. McCall has been the Case Distinguished University Chair of the Department of Psychiatry and Health Behavior at the Medical College of Georgia (MCG) at Augusta University since 2012. He also serves as Executive Vice Dean of MCG. He completed his medical degree and post-graduate psychiatric training at Duke University. He completed a Masters degree in Epidemiology from Wake Forest University. He is board certified in general psychiatry, geriatric psychiatry, and sleep medicine. His research interests include depression, electroconvulsive therapy, quality of life, insomnia, and suicide. He received 22 years of research support from the National Institute of Mental Health, and he has 500 citations, including more than 210 peer-reviewed journal articles, with an H-index of 40. He is Editor of the Journal of ECT, Past Associate Editor for the Journal of Clinical Sleep Medicine, and on the Editorial Board of Sleep. He has been the Past President of the Association for Convulsive Therapy, and a prior Director of the Board of the American Academy of Sleep Medicine. He previously was the Chair of Psychiatry and Behavioral Medicine at Wake Forest University School of Medicine from 2001-2012.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

This video is a replay of a plenary session from the 12th Annual Chair Summit Master Class for Neuroscience Professional Development held in Las Vegas, NV from February 27 – 29, 2020.

Learning Objectives

At the end of this CME/CE activity, participants should be able to:

  • Query your patients about insomnia to facilitate diagnosis and treatment to reduce the personal, clinical, and societal burden it imposes.
  • Examine the role of orexin in sleep/wake regulation to facilitate treatment selection, particularly in the elderly and those with comorbid conditions.
  • Incorporate clinical trial updates on dual orexin reuptake inhibitors to identify effective strategies to safely manage insomnia, particularly in older adults with high medical burden and poly pharmacy.

Financial Support

This activity is supported by an educational grant from Eisai Inc.

Target Audience

Physicians, physician assistants, nurse practitioners, pharmacists, certified case managers, social workers, and other non-physician healthcare professionals with an interest in psychiatry, neurology, and the neurosciences.

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.
Activity UAN: 0376-0000-20-084-H01-P

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit ™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to PAs

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. McCall reports that he receives research support from MECTA Corporation; Merck & Co., Inc.; and VistaGen Therapeutics, Inc. He serves on the advisory committee for Jazz Pharmaceuticals, Inc.; and Sage Therapeutics, Inc. He is a consultant for Jazz Pharmaceuticals, Inc.; and Sage Therapeutics, Inc. He receives other financial or material support in the form of royalties from Wolters Kluwer Publishing.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

  • Howard Bliwise, MD (peer reviewer)
  • Mae Ochoa, RPh (peer reviewer)
  • Kashemi D. Rorie, PhD (planning committee)
  • Evan Luberger (planning committee)
  • Jan Perez (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

 

NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-20-084-H01-P.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

CHV-094-061620-63

Updates on the Management of Insomnia: Expert Guidance Through the Latest Clinical Trials on Dual Orexin Receptor Antagonists
Event Date: 06/16/2020